ARTICLE | Company News
Dutalys, Roche deal
December 22, 2014 8:00 AM UTC
Roche acquired antibody developer Dutalys for $133.8 million in cash up front and up to $355 million in undisclosed milestones. Roche plans to use Dutalys’ DutaMab technology to develop human bispecif...